Figure 3

No significant difference was observed for progression free survival whether patients were treated early in the time course or received RT for tumor recurrence, p-value = 0.37.
No significant difference was observed for progression free survival whether patients were treated early in the time course or received RT for tumor recurrence, p-value = 0.37.